Independent of endogenous expression levels and comparable to previous results in colon carcinoma cells, profound SATB1 knockdown was achieved in all cell lines as verified on the mRNA level, with a ~80–90% knockdown efficacy (Suppl. The gene discussed is SATB1; the disease is colon carcinoma.